as on October 30, 2025 at 7:38 pm IST
Day's Low
Day's High
0.66%
Downside
3.95%
Upside
52 Week's Low
52 Week's High
33.55%
Downside
192.11%
Upside
Check Zentalis Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$123.4M
EPS (TTM)
-1.9571
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-170.4M
Revenue (TTM)
26.9M
Profit Margin
0.00%
Return On Equity TTM
-49.55%
Compare market cap, revenue, PE, and other key metrics of Zentalis Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $123.4M | -96.14% | NA | 0.00% | |
| BUY | $62.4B | 291.63% | -505.15 | -12.96% | |
| NA | $36.4B | NA | NA | -3.89% | |
| BUY | $108.3B | 100.24% | 30.02 | 31.86% | |
| BUY | $69.4B | 20.12% | 15.7 | 32.13% |
The Zentalis Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Zentalis Pharmaceuticals Inc investment value today
Current value as on today
₹61,963
Returns
Returns from Zentalis Pharmaceuticals Inc Stock
Dollar Returns*
₹5,667 (+5.67%)
Based on 17 analysts
82.35%
Buy
17.65%
Hold
0.00%
Sell
Based on 17 analysts, 82.35% of analysts recommend a 'BUY' rating for Zentalis Pharmaceuticals Inc. Average target price of $6.19
Get share price movements and forecasts by analysts on Zentalis Pharmaceuticals Inc.
What analysts predicted
75.44%UPSIDE
Target Price
$6.19
Current Price
$1.52
Analyzed by
17 Analysts
Target
$6.19
Zentalis Pharmaceuticals Inc target price $6.19, a slight upside of 75.44% compared to current price of $1.52. According to 17 analysts rating.
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 135.5% return, outperforming this stock by 229.4%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.1% return, outperforming this stock by 114.4%
Price Dip
![]()
In the last 3 years, ZNTL stock has moved down by -93.9%
| Organisation | Zentalis Pharmaceuticals Inc |
| Headquarters | 10275 Science Center Dr., San Diego, CA, United States, 92121 |
| Industry | Health Technology |
| CEO | Ms. Julie M. Eastland M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. James B. Bucher J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Robert J. DiVasto P.E. | Senior Vice President of Technical Operations |
Mr. Haibo Wang | Chief Business Officer |
Mr. Rajesh Israni | Senior VP of Regulatory Affairs & Medical Writing |
Mr. Henry Gu | Senior VP & Head of Intellectual Property |
Ms. Julie M. Eastland M.B.A. | CEO, President & Director |
Mr. Vincent A. Vultaggio | SVP of Finance & Principal Accounting Officer |
Ms. Wendy Chang | Chief People Officer |
Dr. Ingmar Bruns M.D., Ph.D. | Chief Medical Officer |
Zentalis Pharmaceuticals Inc share price today is $1.52 as on . Zentalis Pharmaceuticals Inc share today touched a day high of $1.58 and a low of $1.51.
Zentalis Pharmaceuticals Inc share touched a 52 week high of $4.44 on and a 52 week low of $1.01 on . Zentalis Pharmaceuticals Inc stock price today i.e. is trending at $1.52,which is 65.77% down from its 52 week high and 50.50% up from its 52 week low.
Zentalis Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Zentalis Pharmaceuticals Inc (ZNTL) shares with as little as ₹88.686 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.86 in Zentalis Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Zentalis Pharmaceuticals Inc share’s latest price of $1.52 as on October 30, 2025 at 7:38 pm IST, you will get 6.5789 shares of Zentalis Pharmaceuticals Inc. Learn more about
fractional shares .
Zentalis Pharmaceuticals Inc stock has given -96.14% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?